Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro immunomodulatory activity of ruthenium complexes.

J R Newcomb1, B Rivnay, C M Bastos

  • 1Amgen Inc, One Kendall Square, Cambridge, MA 02139, USA. jnewcomb@amgen.com.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|July 2, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an antiperspirant with emollients on foot-sweat accumulation and blister formation while walking in the heat.

Journal of the American Academy of Dermatology·1995
Same author

The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy.

International journal of radiation oncology, biology, physics·1995
Same author

Entry of microbes into the host: using M cells to break the mucosal barrier.

Current opinion in immunology·1995
Same author

Derivation of the optimum dose per fraction from the linear quadratic model.

The British journal of radiology·1995
Same author

On the nature of the mutation in the nude rat.

Trends in genetics : TIG·1995
Same author

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Postgraduate medical journal·1995

Ruthenium complexes (RCs) effectively inhibit T cell receptor-mediated stimulation and proliferation in human lymphocytes. These novel compounds offer new avenues for investigating T cell signaling and immunosuppression.

Area of Science:

  • Immunology
  • Medicinal Chemistry
  • Cell Biology

Background:

  • The immunomodulatory potential of ruthenium complexes (RCs) remains underexplored.
  • Understanding novel immunosuppressive agents is crucial for treating autoimmune diseases and managing organ transplantation.

Purpose of the Study:

  • To investigate the in vitro immunomodulatory effects of pure ruthenium red and novel RCs.
  • To assess the impact of RCs on T cell receptor (TCR)-mediated stimulation and immune cell function.

Main Methods:

  • Human peripheral blood lymphocytes (hPBL) and T cells were treated with RCs.
  • Assays included immune function, cytotoxicity, cell cycle progression, and IL-2 secretion.
  • TCR-mediated stimulation by various agents was evaluated.

Related Experiment Videos

Main Results:

  • RCs potently inhibited TCR-mediated stimulation of hPBL (low nM IC50) without cytotoxicity.
  • RCs demonstrated antiproliferative activity against B cells and some non-lymphoid cell lines at higher concentrations.
  • Inhibition occurred at the level of T cell proliferation, IL-2 secretion, CD25 upregulation, and cell cycle progression (G0/G1 to S phase).

Conclusions:

  • RCs exhibit potent immunomodulatory effects, primarily through inhibition of T cell activation and proliferation.
  • The distinct mechanism of action from rapamycin and cyclosporin A suggests RCs as valuable tools for T cell signaling research.
  • RCs may offer novel therapeutic opportunities for immunosuppression.